Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.

Stefan H, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M, Kasper BS, Hammen T, Rzonsa M, Pauli E, Ellrich J, Graf W, Hopfengärtner R.

Epilepsia. 2012 Jul;53(7):e115-8. doi: 10.1111/j.1528-1167.2012.03492.x. Epub 2012 May 3.

2.

Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex.

Kosel M, Brockmann H, Frick C, Zobel A, Schlaepfer TE.

Psychiatry Res. 2011 Mar 31;191(3):153-9. doi: 10.1016/j.pscychresns.2010.11.004.

PMID:
21306877
3.

Prognostic significance of QRS duration and morphology.

Brenyo A, Zaręba W.

Cardiol J. 2011;18(1):8-17. Review.

4.

Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.

Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.

J Clin Psychiatry. 2011 Oct;72(10):1376-82. doi: 10.4088/JCP.09m05888blu.

PMID:
21295002
5.

Reversing pathological neural activity using targeted plasticity.

Engineer ND, Riley JR, Seale JD, Vrana WA, Shetake JA, Sudanagunta SP, Borland MS, Kilgard MP.

Nature. 2011 Feb 3;470(7332):101-4. doi: 10.1038/nature09656. Epub 2011 Jan 12.

6.

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.

De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ; CardioFit Multicenter Trial Investigators.

Eur Heart J. 2011 Apr;32(7):847-55. doi: 10.1093/eurheartj/ehq391. Epub 2010 Oct 28.

7.

Efficacy of vagus nerve stimulation in the treatment of depression.

Grimm S, Bajbouj M.

Expert Rev Neurother. 2010 Jan;10(1):87-92. doi: 10.1586/ern.09.138. Review.

PMID:
20021323
8.

Chronic vagal stimulation in patients with congestive heart failure.

De Ferrari GM, Sanzo A, Schwartz PJ.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:2037-9. doi: 10.1109/IEMBS.2009.5334414.

PMID:
19964772
9.

Long term vagal stimulation in patients with advanced heart failure: first experience in man.

Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, Campana C, Revera M, Ajmone-Marsan N, Tavazzi L, Odero A.

Eur J Heart Fail. 2008 Sep;10(9):884-91. doi: 10.1016/j.ejheart.2008.07.016. Epub 2008 Aug 28.

10.

[A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI].

Dietrich S, Smith J, Scherzinger C, Hofmann-Preiss K, Freitag T, Eisenkolb A, Ringler R.

Biomed Tech (Berl). 2008 Jun;53(3):104-11. doi: 10.1515/BMT.2008.022.

PMID:
18601618
11.

Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism.

Pardo JV, Sheikh SA, Schwindt GC, Lee JT, Kuskowski MA, Surerus C, Lewis SM, Abuzzahab FS, Adson DE, Rittberg BR.

Neuroimage. 2008 Aug 15;42(2):879-89. doi: 10.1016/j.neuroimage.2008.04.267. Epub 2008 May 15.

12.

Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study.

Vonck K, De Herdt V, Bosman T, Dedeurwaerdere S, Van Laere K, Boon P.

Seizure. 2008 Dec;17(8):699-706. doi: 10.1016/j.seizure.2008.05.001. Epub 2008 Jun 16.

13.

Anatomical and physiological basis and mechanism of action of neurostimulation for epilepsy.

Vonck K, Boon P, Van Roost D.

Acta Neurochir Suppl. 2007;97(Pt 2):321-8. Review.

PMID:
17691318
14.

BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation.

Kraus T, Hösl K, Kiess O, Schanze A, Kornhuber J, Forster C.

J Neural Transm (Vienna). 2007;114(11):1485-93. Epub 2007 Jun 14.

PMID:
17564758
15.

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, George MS, Charney DS, Brannan SK.

Neuropsychopharmacology. 2006 Jul;31(7):1345-55. Epub 2006 Apr 19. Review. Erratum in: Neuropsychopharmacology. 2006 Oct;31(10):2329.

16.

Significance of QRS complex duration in patients with heart failure.

Kashani A, Barold SS.

J Am Coll Cardiol. 2005 Dec 20;46(12):2183-92. Review.

17.

A review of functional neuroimaging studies of vagus nerve stimulation (VNS).

Chae JH, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE, George MS.

J Psychiatr Res. 2003 Nov-Dec;37(6):443-55. Review.

PMID:
14563375
18.

Vagus-nerve stimulation for the treatment of epilepsy.

Ben-Menachem E.

Lancet Neurol. 2002 Dec;1(8):477-82. Review.

PMID:
12849332
19.

The nerve supply of the human auricle.

Peuker ET, Filler TJ.

Clin Anat. 2002 Jan;15(1):35-7.

PMID:
11835542
20.

Intraventricular conduction delay: a prognostic marker in chronic heart failure.

Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, Coats AJ.

Int J Cardiol. 1999 Jul 31;70(2):171-8.

PMID:
10454306
Items per page

Supplemental Content

Write to the Help Desk